3,6,9,12,15,18-Hexaoxaheneicos-20-yn-1-amine, 97%, 1g

(R)-quinuclidine-2-carboxylic acid hydrochloride, 97%, 1g

GC capillary column ROTI®Cap-FFAP, 60 m, 0.25 mm, 0.25 µm, 1 Piece(s)

2,2,3,3,3-Pentafluoropropyltriflate, 95.0%, 5g

ROTI®Cell Freezing Medium

4-Hydroxy-3,5-dimethylbenzaldehyde>98.0%(T)25g

3-Bromo-2-chloro-5-fluorobenzotrifluoride, 95+%, 1g

2-(9-Oxoxanthen-2-yl)propionic Acid 1,5,7-Triazabicyclo[4.4.0]dec-5-ene Salt>98.0%(HPLC)1g

4-N-Boc-2-Oxo-piperazine, 97.00%, 25g

(Diethylamino)sulfur Trifluoride [Fluorinating Reagent]>90.0%(T)25g

2-Methyl-3-methylsulfanyl-pyrazine, 98.0%, 100g

Phenanthren-9-ol, 95.0%, 25g

1-Benzyl-4,6-dimethylpiperidin-3-amine dihydrochloride, 97.0%, 1g